Amy Rabideau, Ph.D.Senior Scientist, Drug Substance Process Development at Moderna
Dr. Amy Rabideau is a Senior Scientist in the Drug Substance Process Development team at Moderna in Cambridge, MA, a biotechnology company focused on producing messenger RNA medicines. As a research scientist and team leader at Moderna, Amy works to identify and refine strategies used to produce highly pure mRNA for vaccine and therapeutic development. Prior to working at Moderna, Amy received her Ph.D. in Biological Chemistry from MIT, under the mentorship of Associate Professor Brad Pentelute. She completed her B.S. in Chemistry and Biology with honors from Syracuse University.